Henry Schein, Inc. HSIC
Set alert
At close
Pre-market · Nov 3, 7:04 AM ET
- YTD
- +14.61%
- 1 year
- +34.00%
- Open
- 85.93
- Prev close
- 84.88
- Mkt cap
- 9.87B
- Vol
- 2.50M
- Avg vol
- 1.17M
- EPS
- 3.43
- P/E
- 25.25
- Div yield
- 0.00%
More statistics
- Low
- 85.38
- High
- 87.28
- Forward P/E
- 14.46
- Beta
- 0.86
- Short ratio
- 6.93
- Inst. own
- 111.14%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 86.53
- 200-d avg
- 81.06
- 1y target
- 96.87
5D chart
Signals (114)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 3:50 PM | 15 hours ago |
| SMA: Bullish | Nov 2, 3:45 PM | 16 hours ago |
| SMA: Bearish | Nov 2, 3:40 PM | 16 hours ago |
| SMA: Bullish | Nov 2, 3:35 PM | 16 hours ago |
| SMA: Bearish | Nov 2, 3:15 PM | 16 hours ago |
| SMA: Bullish | Nov 2, 3:10 PM | 16 hours ago |
| SMA: Bearish | Nov 2, 2:30 PM | 17 hours ago |
| SMA: Bullish | Nov 2, 2:20 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 2:15 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 1:45 PM | 18 hours ago |
| MACD: Sell Signal | Nov 2, 1:45 PM | 18 hours ago |
| MACD: Buy Signal | Nov 2, 1:25 PM | 18 hours ago |
| SMA: Bullish | Nov 2, 1:00 PM | 18 hours ago |
| SMA: Bearish | Nov 2, 12:10 PM | 19 hours ago |
| MACD: Sell Signal | Nov 2, 12:05 PM | 19 hours ago |
| RSI: Overbought | Nov 2, 11:35 AM | 20 hours ago |
| RSI: Overbought | Nov 2, 11:25 AM | 20 hours ago |
| MACD: Buy Signal | Nov 2, 10:50 AM | 20 hours ago |
| SMA: Bullish | Nov 2, 10:45 AM | 21 hours ago |
| MACD: Sell Signal | Nov 2, 10:30 AM | 21 hours ago |
Newest 20 of 114.
News
-
1 hour ago benzinga.com
Henry Schein Raises FY2026 Adj EPS Guidance from $5.29-$5.39 to $5.50-$5.56 vs $5.39 Est; Affirms FY2026 Sales Guidance of $13.794B-$13.926B vs $13.866B Est
Henry Schein (NASDAQ:HSIC) raises FY2026 Adj EPS guidance from $5.29-$5.39 to $5.50-$5.56 vs $5.39 analyst estimate. Affirms FY2026 sales outlook from $13.794 billion-$13.926 billion to $13.794…
-
1 hour ago benzinga.com
Henry Schein Q3 Adj. EPS $1.56 Beats $1.36 Estimate, Sales $3.471B Miss $3.476B Estimate
Henry Schein (NASDAQ:HSIC) reported quarterly earnings of $1.56 per share which beat the analyst consensus estimate of $1.36 by 14.71 percent. This is a 13.04 percent increase over earnings of $1.38…
1 hour ago businesswire.com
Henry Schein Reports Strong 2026 Third Quarter and Raises FY2026 Guidance
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, today reported financial…
3 days ago zacks.com
Why Henry Schein (HSIC) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
6 days ago zacks.com
Analysts Estimate Henry Schein (HSIC) to Report a Decline in Earnings: What to Look Out for
Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
6 days ago zacks.com
Henry Schein to Report Q3 Earnings: Here's What You Should Know
HSIC gears up for Q3 earnings with revenue growth expected across its three segments, fueled by dental products, specialty demand and cloud-based technology.
-
2 weeks ago benzinga.com
Leerink Partners Maintains Market Perform on Henry Schein, Lowers Price Target to $92
Leerink Partners analyst Michael Cherny maintains Henry Schein (NASDAQ:HSIC) with a Market Perform and lowers the price target from $96 to $92.
1 month ago benzinga.com
Transcript: Henry Schein Q2 2026 Earnings Conference Call
Henry Schein (NASDAQ:HSIC) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive…
1 month ago benzinga.com
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers IM Cannabis (NASDAQ:IMCC) stock rose 56.3% to $6.47 during Wednesday's pre-market session. The company's market cap stands at $2.5 million. Vistagen Therapeutics (NASDAQ:VTGN) shares…
2 months ago benzinga.com
Palo Alto To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday
Analysts changed outlook on top names. Piper Sandler raises Mercury Systems' target price, Ascendiant Capital boosts Alzamend Neuro's target price, BTIG raises Henry Schein's target price, Cantor…
-
2 months ago benzinga.com
BTIG Maintains Buy on Henry Schein, Raises Price Target to $110
BTIG analyst David Larsen maintains Henry Schein (NASDAQ:HSIC) with a Buy and raises the price target from $100 to $110.
-
2 months ago benzinga.com
Barclays Maintains Overweight on Henry Schein, Raises Price Target to $100
Barclays analyst Glen Santangelo maintains Henry Schein (NASDAQ:HSIC) with a Overweight and raises the price target from $86 to $100.
-
2 months ago benzinga.com
UBS Maintains Neutral on Henry Schein, Raises Price Target to $94
UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and raises the price target from $89 to $94.
-
2 months ago benzinga.com
Citigroup Maintains Buy on Henry Schein, Raises Price Target to $112
Citigroup analyst Daniel Grosslight maintains Henry Schein (NASDAQ:HSIC) with a Buy and raises the price target from $100 to $112.
-
3 months ago benzinga.com
Henry Schein Q2 2026 Earnings Call: Complete Transcript
Henry Schein (NASDAQ:HSIC) reported second-quarter financial results on Tuesday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to…
-
3 months ago benzinga.com
Henry Schein Raises FY2026 Adj EPS Guidance from $5.23-$5.37 to $5.29-$5.39 vs $5.33 Est; Raises FY2026 Sales Guidance from $13.580B-$13.843B to $13.794B-$13.926B vs $13.738B Est
Henry Schein (NASDAQ:HSIC) raises FY2026 Adj EPS guidance from $5.23-$5.37 to $5.29-$5.39 vs $5.33 analyst estimate. Raises FY2026 sales outlook from $13.580 billion-$13.843 billion to $13.794…
-
3 months ago benzinga.com
Henry Schein Q2 Adj. EPS $1.27 Beats $1.24 Estimate, Sales $3.458B Beat $3.375B Estimate
Henry Schein (NASDAQ:HSIC) reported quarterly earnings of $1.27 per share which beat the analyst consensus estimate of $1.24 by 2.42 percent. This is a 15.45 percent increase over earnings of $1.10…
-
3 months ago benzinga.com
Piper Sandler Maintains Overweight on Henry Schein, Raises Price Target to $95
Piper Sandler analyst Jason Bednar maintains Henry Schein (NASDAQ:HSIC) with a Overweight and raises the price target from $91 to $95.
-
3 months ago benzinga.com
UBS Maintains Neutral on Henry Schein, Raises Price Target to $89
UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and raises the price target from $85 to $89.
-
3 months ago benzinga.com
BMO Capital Initiates Coverage On Henry Schein with Market Perform Rating, Announces Price Target of $85
BMO Capital initiates coverage on Henry Schein (NASDAQ:HSIC) with a Market Perform rating and announces Price Target of $85.
4 months ago benzinga.com
This MarketAxess Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday
Wall Street analysts changed outlook on top names like MKTX, PRCT, VOD, and JILL. See ratings page and analysts' views before buying MKTX stock.
4 months ago benzinga.com
This Henry Schein Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Wall Street analysts change outlook for top stocks. See upgrades, downgrades, and initiations on analyst ratings page. HSIC stock analysis.
-
4 months ago benzinga.com
BTIG Upgrades Henry Schein to Buy, Announces $100 Price Target
BTIG analyst David Larsen upgrades Henry Schein (NASDAQ:HSIC) from Neutral to Buy and announces $100 price target.
-
5 months ago benzinga.com
Henry Schein Appoints William K. Daniel As Board Chairman, Effective Immediately
Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Board of Directors has elected…
-
6 months ago benzinga.com
UBS Maintains Neutral on Henry Schein, Lowers Price Target to $85
UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and lowers the price target from $87 to $85.
-
6 months ago benzinga.com
Mizuho Maintains Neutral on Henry Schein, Lowers Price Target to $82
Mizuho analyst Steven Valiquette maintains Henry Schein (NASDAQ:HSIC) with a Neutral and lowers the price target from $88 to $82.
6 months ago benzinga.com
Transcript: Henry Schein Q1 2026 Earnings Conference Call
Transcript: Henry Schein Q1 2026 Earnings Conference Call
-
6 months ago benzinga.com
Henry Schein Affirms FY2026 Adj EPS Guidance of $5.23-$5.37 vs $5.32 Est; Affirms FY2026 Sales Guidance of $13.580B-$13.843B vs $13.717B Est
Henry Schein (NASDAQ:HSIC) affirms FY2026 Adj EPS guidance from $5.23-$5.37 to $5.23-$5.37 vs $5.32 analyst estimate. Affirms FY2026 sales outlook from $13.580 billion-$13.843 billion to $13.580…
-
6 months ago benzinga.com
Henry Schein Q1 Adj. EPS $1.32 Beats $1.22 Estimate, Sales $3.368B Beat $3.342B Estimate
Henry Schein (NASDAQ:HSIC) reported quarterly earnings of $1.32 per share which beat the analyst consensus estimate of $1.22 by 8.2 percent. This is a 14.78 percent increase over earnings of $1.15…
-
6 months ago benzinga.com
Morgan Stanley Maintains Underweight on Henry Schein, Raises Price Target to $64
Morgan Stanley analyst Erin Wright maintains Henry Schein (NASDAQ:HSIC) with a Underweight and raises the price target from $61 to $64.
6 months ago benzinga.com
This Dick's Sporting Goods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
Top analysts change outlook on top names, check analyst ratings page for all changes. Keybanc initiated Overweight rating on KALU with $170 PT.
-
6 months ago benzinga.com
Citigroup Initiates Coverage On Henry Schein with Buy Rating, Announces Price Target of $100
Citigroup analyst Daniel Grosslight initiates coverage on Henry Schein (NASDAQ:HSIC) with a Buy rating and announces Price Target of $100.
-
6 months ago benzinga.com
Evercore ISI Group Maintains Outperform on Henry Schein, Lowers Price Target to $90
Evercore ISI Group analyst Elizabeth Anderson maintains Henry Schein (NASDAQ:HSIC) with a Outperform and lowers the price target from $100 to $90.
-
6 months ago benzinga.com
Henry Schein Chairman Stanley M. Bergman to Retire After 44 Years, Board Shrinks to 10 Members
Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of healthcare solutions to office-based dental and medical practitioners, today announced its plan to reduce the size of its Board of…
-
8 months ago benzinga.com
Biomerica Announces Responder Analysis Results From Ongoing Real-World Study Of inFoods IBS
Responder Analysis: 59.4% of patients achieved ≥30% reduction in abdominal pain; 68.1% achieved ≥30% reduction in bloating—using the FDA-recognized responder endpoint consistent with the Company's…
-
8 months ago benzinga.com
Barrington Research Maintains Outperform on Henry Schein, Raises Price Target to $97
Barrington Research analyst Michael Petusky maintains Henry Schein (NASDAQ:HSIC) with a Outperform and raises the price target from $79 to $97.
-
8 months ago benzinga.com
UBS Maintains Neutral on Henry Schein, Raises Price Target to $87
UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and raises the price target from $79 to $87.
-
8 months ago benzinga.com
JP Morgan Maintains Overweight on Henry Schein, Raises Price Target to $92
JP Morgan analyst John Stansel maintains Henry Schein (NASDAQ:HSIC) with a Overweight and raises the price target from $78 to $92.
8 months ago benzinga.com
These Analysts Increase Their Forecasts On Henry Schein After Upbeat Q4 Results
These Analysts Increase Their Forecasts On Henry Schein After Upbeat Q4 Results
-
8 months ago benzinga.com
Mizuho Maintains Neutral on Henry Schein, Raises Price Target to $88
Mizuho analyst Steven Valiquette maintains Henry Schein (NASDAQ:HSIC) with a Neutral and raises the price target from $81 to $88.
-
8 months ago benzinga.com
Morgan Stanley Maintains Underweight on Henry Schein, Raises Price Target to $61
Morgan Stanley analyst Erin Wright maintains Henry Schein (NASDAQ:HSIC) with a Underweight and raises the price target from $58 to $61.
-
8 months ago benzinga.com
Wells Fargo Maintains Equal-Weight on Henry Schein, Raises Price Target to $87
Wells Fargo analyst Vik Chopra maintains Henry Schein (NASDAQ:HSIC) with a Equal-Weight and raises the price target from $76 to $87.
-
8 months ago benzinga.com
Evercore ISI Group Maintains Outperform on Henry Schein, Raises Price Target to $100
Evercore ISI Group analyst Elizabeth Anderson maintains Henry Schein (NASDAQ:HSIC) with a Outperform and raises the price target from $90 to $100.
8 months ago benzinga.com
Analyst Expectations For Henry Schein's Future
Analyst Expectations For Henry Schein's Future
-
8 months ago benzinga.com
Leerink Partners Maintains Market Perform on Henry Schein, Raises Price Target to $87
Leerink Partners analyst Michael Cherny maintains Henry Schein (NASDAQ:HSIC) with a Market Perform and raises the price target from $75 to $87.
8 months ago benzinga.com
Henry Schein Stock Hits 52-Week High - Here's Why
Henry Schein beats Q4 earnings and sales estimates, guides steady 2026 growth as shares climb nearly 10% Tuesday.
8 months ago benzinga.com
Henry Schein, Vir Biotechnology, Ultra Clean Holdings And Other Big Stocks Moving Higher On Tuesday
Henry Schein, Vir Biotechnology, Ultra Clean Holdings And Other Big Stocks Moving Higher On Tuesday
-
8 months ago benzinga.com
Earnings Scheduled For February 24, 2026
Earnings Scheduled For February 24, 2026
-
8 months ago benzinga.com
Henry Schein Sees FY2026 Adj EPS $5.23-$5.37 vs $5.30 Est; Sees Sales $13.580B-$13.843B vs $13.533B Est. Revenue expected to grow 3% to 5% from FY 2025 $13.184B.
Henry Schein (NASDAQ:HSIC) is looking for FY2026 Adj EPS of $5.23-$5.37 vs $5.30 analyst estimate. sees sales of $13.580 billion-$13.843 billion vs $13.533 billion analyst estimate.